A new biomarker discovered using cutting-edge technologies is found in people who develop scleroderma and cancer within a short period of time.
Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer
News
Improving Immunization Rates in Adults with Rheumatic Diseases
Vaccines have been scientifically proven to save lives, increase lifespans, and maintain quality of life. Currently, only 39% of adults receive an annual flu shot. There are specific steps that can be taken to improve the vaccination rate. This is especially important in the immuno-compromised population.
Hopkins Rheumatology helps to #CUREMyositis
On Saturday October 15, 2016, the Hopkins Rheumatology CARES (Centers Advancing RESearch) team was out in full force to support the “Myositis Run, Walk, n’ Roll 5k” event at Centennial Park in Columbia, MD.
The relationship between Sjögren’s syndrome and central nervous system disorders
This study explored the relationship between subtypes of demyelinating disorders and Sjogren’s syndrome. These findings help identify the spectrum of neurological disease directly attributable to SS.
Patients and doctors decide what to measure in clinical trials for Psoriatic Arthritis
Patients and physicians came together in this international project to agree on what is critical to be measured in psoriatic arthritis clinical trials. This project was critical in defining what outcomes are important for both patients and their doctors.
Durable Remission is Rare in Systemic Lupus Erythematosus
The authors found that just very few patients reach durable remission, regardless of defining remission on-treatment or off-treatment. The higher the patients’ disease activity and treatment was when they entered our analysis, the lower was their chance of achieving remission.
